We are live on ! Find out more
ADAG

Adagene

13 hedge funds and large institutions have $25.3M invested in Adagene in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0.12% less ownership

Funds ownership: 20.33%20.21% (-0.12%)

7% less funds holding

Funds holding: 1413 (-1)

25% less capital invested

Capital invested by funds: $33.7M → $25.3M (-$8.39M)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
13
Holders Change
-1
Holders Change %
-7.14%
% of All Funds
0.19%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
1
Increased
2
Reduced
3
Closed
2
Calls
Puts
Net Calls
Net Calls Change

ADAG Hedge Fund Activity: Q3 2024 in Review

13 of the 6,967 institutional investors tracked by Wall St. Rank reported a position in Adagene (ADAG) for Q3 2024, worth a combined $25.3M — down 25% from $33.7M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of ADAG and 1 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 2 added.

The largest buyer was Exome Asset Management, adding an estimated $294K. The largest seller was Fidelity International, cutting an estimated $595K.

  • 13 institutional investors held Adagene (ADAG) as of Q3 2024, down from 14 in Q2 2024.
  • Funds reported $25.3M of Adagene stock for Q3 2024, down 25% quarter-over-quarter.
  • 1 fund opened new Adagene positions in Q3 2024 and 2 closed out, a net change of -1 holder.
  • The largest Adagene buyer in Q3 2024 was Exome Asset Management, an estimated $294K added.
  • The largest Adagene seller in Q3 2024 was Fidelity International, an estimated $595K sold.

Based on aggregated 13F filings for Q3 2024.